Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Standard titration protocol from clinical trials The Phase 2 NEJM trial used the following escalation schedule for the 12 mg dose group: Weeks 1 through 4: 2 mg once weekly (subcutaneous) Weeks 5 through 8: 4 mg once weekly Weeks 9 through 12: 8 mg once weekly Week 13 and beyond: 12 mg once weekly (maintenance dose) For the 8 mg target dose, the schedule was: Weeks 1 through 4: 2 mg once weekly Weeks 5 through 8: 4 mg once weekly Week 9 and beyond: 8 mg once weekly (maintenance dose) These titration schedules are not suggestions
Targeted Fat Reduction : AOD 9604 specifically addresses resistant fat areas that often don't respond to conventional weight loss methods
The innate repair receptor concept a damage-selective tissue repair pathway that can be pharmacologically activated without erythropoietic side effects is scientifically compelling and has been validated by the clinical data showing measurable nerve regeneration
No account required, no data stored
